학술논문

Real life data on nintedanib safety: idiopathic pulmonary fibrosis versus systemic sclerosis-interstitial lung disease and strategies adopted to manage adverse effects
Document Type
Article
Source
In: Inflammopharmacology. (Inflammopharmacology, October 2023, 31(5):2445-2449)
Subject
Language
English
ISSN
15685608
09254692